<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39342452</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2877</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Sep</Month><Day>28</Day></PubDate></JournalIssue><Title>Public health reports (Washington, D.C. : 1974)</Title><ISOAbbreviation>Public Health Rep</ISOAbbreviation></Journal><ArticleTitle>Increased Identification of Vaccines for Vaccine Safety Surveillance Through Linkage With the Minnesota Immunization Information Connection as of December 31, 2023.</ArticleTitle><Pagination><StartPage>333549241280002</StartPage><MedlinePgn>333549241280002</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/00333549241280002</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">The HealthPartners' Vaccine Safety Datalink (VSD) team maintains standardized files of vaccines from medical and pharmacy claims and electronic health records (established data sources) for safety surveillance. Since 2021, for selected vaccines, data from the Minnesota Immunization Information Connection (MIIC), Minnesota's immunization information system, have been added to the HealthPartners' VSD files. We examined how MIIC data have enhanced the identification of novel and routine vaccines.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We describe the approach to incorporating MIIC data. We determined and compared the number and proportion of vaccines identified from established data sources with the additional capture of vaccine data identified from MIIC, in which age group and period of observation varied by vaccine.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">As of December 31, 2023, of 1 099 411 people in the HealthPartners' VSD cohort, 1 001 400 people (91%) were linked with an MIIC record. Across all data sources, for the full cohort, &gt;2.7 million COVID-19 vaccine doses were recorded since 2020, &gt;4000 mpox vaccine doses since 2022, &gt;7.3 million influenza vaccine doses since 2004, &gt;600 000 human papillomavirus (HPV) vaccine doses since 2006, and &gt;1.1 million diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine doses since 2004. For COVID-19 vaccines, about 30% of vaccine doses were exclusively captured from MIIC, with the remaining 70% from established data sources. For the mpox vaccine, about 42% were exclusively from MIIC. For influenza, HPV, and DTaP vaccines, about 20%, 14%, and 17%, respectively, were exclusively identified from MIIC.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Incorporation of data from state immunization information systems into existing vaccine data files can enhance monitoring on the safety of novel vaccines administered outside traditional health care settings and can enhance data quality for routine childhood and adult vaccines.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Jingyi</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0008-1725-5305</Identifier><AffiliationInfo><Affiliation>HealthPartners Institute, Bloomington, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vazquez-Benitez</LastName><ForeName>Gabriela</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>HealthPartners Institute, Bloomington, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeSilva</LastName><ForeName>Malini B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>HealthPartners Institute, Bloomington, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuckler</LastName><ForeName>Leslie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>HealthPartners Institute, Bloomington, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trower</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>HealthPartners Institute, Bloomington, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muscoplat</LastName><ForeName>Miriam Halstead</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Minnesota Department of Health, St. Paul, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bieringer</LastName><ForeName>Aaron</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Minnesota Department of Health, St. Paul, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Groom</LastName><ForeName>Holly C</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Center for Health Research, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kharbanda</LastName><ForeName>Elyse O</ForeName><Initials>EO</Initials><AffiliationInfo><Affiliation>HealthPartners Institute, Bloomington, MN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Public Health Rep</MedlineTA><NlmUniqueID>9716844</NlmUniqueID><ISSNLinking>0033-3549</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">immunization information system</Keyword><Keyword MajorTopicYN="N">safety</Keyword><Keyword MajorTopicYN="N">surveillance</Keyword><Keyword MajorTopicYN="N">vaccination</Keyword><Keyword MajorTopicYN="N">vaccine uptake</Keyword></KeywordList><CoiStatement>Declaration of Conflicting InterestsThe authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: G.V.B. reports research funding for unrelated work from Sanofi Pasteur and AbbVie, and H.C.G. reports research funding for unrelated work from Moderna.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>2</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39342452</ArticleId><ArticleId IdType="doi">10.1177/00333549241280002</ArticleId></ArticleIdList></PubmedData></PubmedArticle>